Helix BioPharma Corp. Reports Voting Results and Appointment

RICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment

Related Keywords

Toronto , Ontario , Canada , Richmond Hill , Frank Michalargias , Slawomir Majewski , National Instrument , Toronto Stock Exchange , Company Board Of Directors , Helix Biopharma Corp , Helix Biopharma , Disclosure Obligations , Adam Uszpolewicz , Prof Slawomir , Chief Financial , Helix , Iopharma , Orp , Reports , Voting , Results , Appointment , Board , Director ,